References
- Thai T, Salisbury BH, Zito PM. Ciprofloxacin. StatPearls; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535454/. Accessed December 16, 2022.
- WHO. WHO model list of essential medicines - 22nd list. World Heal Organ. 2021. Available from: https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02. Accessed December 24, 2022.
- EFDA. Ethiopian Essential Medicines List. Ministry of Health/Ethiopian Food and Drug Authority; 2020:6.
- Meredith P. Bioequivalence and Other Unresolved Issues in Generic Drug Substitution. Clin Ther. 2003;25(11):2875–2890. doi:10.1016/S0149-2918(03)80340-5
- Sánchez-Vargas FM, Abu-El-Haija MA, Gómez-Duarte OG. Salmonella infections: an update on epidemiology, management, and prevention. Travel Med Infect Dis. 2011;9(6):263–277. doi:10.1016/J.TMAID.2011.11.001
- King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies - PubMed. Croat Med J. 2002;43(4):462–469.
- ASPE. Expanding the Use of Generic Drugs: ASPE Issue Brief. ASPE Issue Br; 2010:1–13.
- Finch R. Generic antibiotics, antibiotic resistance, and drug licensing. Lancet Infect Dis. 2010;10(11):754. doi:10.1016/S1473-3099(10)70246-2
- Taylor RB, Shakoor O, Behrens RH, et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet. 2001;357:1933–1936. doi:10.1016/S0140-6736(00)05065-0
- Butler T, Sridhar CB, Daga MK, et al. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother. 1999;44(2):243–250. doi:10.1093/jac/44.2.243
- Effa EE, Lassi ZS, Critchley JA, et al. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2011;2011:10. doi:10.1002/14651858.CD004530.PUB4
- Umair M, Siddiqui SA. Antibiotic susceptibility patterns of salmonella typhi and salmonella paratyphi in a tertiary care hospital in Islamabad. Cureus. 2020;12:9. doi:10.7759/CUREUS.10228
- Ozawa S, Evans DR, Bessias S, et al. Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: a systematic review and meta-analysis. JAMA Netw open. 2018;1(4):e181662. doi:10.1001/jamanetworkopen.2018.1662
- Delepierre A, Gayot A, Carpentier A. Update on counterfeit antibiotics worldwide; Public health risks. Médecine Mal Infect. 2012;42(6):247–255. doi:10.1016/J.MEDMAL.2012.04.007
- MSF. Drug Quality and Storage. MSF Medical Guidelines; 2022. Available from: https://medicalguidelines.msf.org/en/viewport/EssDr/english/drug-quality-and-storage-16688167.html. Accessed December 16, 2022.
- WHO. Quality assurance of pharmaceuticals: a compendium of guidelines and related materials; 2007. Available from: https://www.who.int/medicines/areas/quality_safety/quality_assurance/QualityAssurancePharmVol2.pdf. Accessed April 21, 2019.
- Newton P, Proux S, Green M, Smithuis F, Nosten F, White NJ. Fake artesunate in Southeast Asia. Lancet. 2001;357:1948–1950. doi:10.1016/S0140-6736(00)05085-6
- Zabala GA, Bellingham K, Vidhamaly V, et al. Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance? BMJ Glob Heal. 2022;7(8):8587. doi:10.1136/BMJGH-2022-008587
- Pisani E. WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products. Geneva: World Health Organization; 2017.
- Johnston A, Holt DW. Substandard drugs: a potential crisis for public health. Br J Clin Pharmacol. 2014;78(2):218–243. doi:10.1111/bcp.12298
- HIMEDIA. Nutrient agar: technical data M001. HiMedia Laboratories Technical Data; 2022. Available from: https://www.himedialabs.com/TD/M001.pdf. Accessed August 13, 2022.
- Vineetha N, Vignesh R, Sridhar D. Preparation, standardization of antibiotic discs and study of resistance pattern for first-line antibiotics in isolates from clinical samples. Int J Appl Res. 2015;1(11):624–631.
- Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. In: Weinstein M, Lewis J, Bobenchik A, editors. CLSI Supplement M100. Vol M100-Ed30. 30th ed. 950 West Valley Road, Suite 2500, Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2020.
- Berhe S, Beyene T, Jibat T, Tadese W. Comparative efficacy evaluation of six brands of amoxicillin against S. aureus isolated from subclinical mastitic milking dairy cows in bishoftu. Adv Dairy Res. 2017;5:169.
- Quinn P, Carter M, Markey B, Carter G. Clinical Veterinary Microbiology. Aust Vet J. 2002;72(6):96–344. doi:10.1111/j.1751-0813.1995.tb03534.x
- Okonko IO, Fajobi EA, Ogunnusi TA, Ogunjobi AA. Antimicrobial chemotherapy and sustainable development: the past, the current trend, and the future. African J Biomed Res. 2009;11:235–250.
- OIE (World Organization for Animal Health). Guideline 2.1. Laboratory Methodologies for Bacterial Antimicrobial Susceptibility Testing. Paris, France: OIE Terrestrial Animal Health Code; 2012.
- FDA. The FDA’s drug review process: ensuring drugs are safe and effective. FDA. U.S.Food & Drug Administration; 2017. Available from: https://www.fda.gov/drugs/information-consumers-and-patients-drugs/fdas-drug-review-process-ensuring-drugs-are-safe-and-effective. Accessed December 24, 2022.
- Bihari M. Are generic drugs as safe and effective as brand-name? Verywell health; 2022. Available from: https://www.verywellhealth.com/generic-drug-safety-and-effectiveness-1738890. Accessed December 24, 2022.
- Eshetie TC, Marcum ZA, Schmader KE, Gray SL. Medication use quality and safety in older adults: 2020 update. J Am Geriatr Soc. 2022;70(2):389–397. doi:10.1111/JGS.17603
- FDA. FDA regulation of animal drugs. FDA. U.S.Food and Drug Administration; 2022. Avilable from: https://www.fda.gov/animal-veterinary/resources-you/fda-regulation-animal-drugs. Accessed December 24, 2022.
- FDA. Generic drug facts. U.S. Food & Drug Administration; 2021. Avilable from: https://www.fda.gov/drugs/generic-drugs/generic-drug-facts. Accessed December 24, 2022.
- Paul M. Assessment of commonly available antimicrobial agents. A study from Ilala Tanzania. Tanzania Med Students’ Assoc. 2009;16:16–22.
- Azoulay P. Do pharmaceutical sales respond to scientific evidence? J Econ Manag Strateg. 2002;11(4):551–594. doi:10.1162/105864002320757262
- FDA. Abbreviated New Drug Application (ANDA); 2019. Available from: https://www.fda.gov/drugs/types-applications/abbreviated-new-drug-application-anda. Accessed May 17, 2020.